Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
81.67
-0.26 (-0.32%)
At close: Jun 5, 2026, 4:00 PM EDT
81.26
-0.41 (-0.50%)
Pre-market: Jun 8, 2026, 9:04 AM EDT
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular | 13.98B | 13.51B | 13.09B | 12.76B | 12.48B | 12.28B | 12.17B | 11.99B | ||||||||||||||
| Cardiovascular Growth | 11.96% | 10.08% | 7.61% | 6.43% | 5.49% | 2.27% | 2.71% | 2.50% | ||||||||||||||
| Neuroscience | 10.29B | 10.16B | 10.06B | 9.95B | 9.85B | 9.77B | 9.67B | 9.51B | ||||||||||||||
| Neuroscience Growth | 4.48% | 3.94% | 4.01% | 4.63% | 4.67% | 5.38% | 5.49% | 4.88% | ||||||||||||||
| Medical Surgery | 8.82B | 8.64B | 8.54B | 8.50B | 8.41B | 8.39B | 8.47B | 8.48B | ||||||||||||||
| Medical Surgery Growth | 4.84% | 2.92% | 0.80% | 0.13% | -1.40% | -0.70% | 0.33% | 1.36% | ||||||||||||||
| Diabetes | 3.11B | 3.00B | 2.90B | 2.83B | 2.76B | 2.69B | 2.63B | 2.56B | ||||||||||||||
| Diabetes Growth | 12.92% | 11.72% | 10.14% | 10.64% | 10.73% | 10.90% | 11.90% | 11.22% | ||||||||||||||
| Other | 174.00M | 171.00M | 171.00M | 173.00M | 48.00M | 74.00M | 59.00M | 44.00M | ||||||||||||||
| Other Growth | 262.50% | 131.08% | 189.83% | 293.18% | -57.14% | 34.55% | 55.26% | 175.00% |
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest of World | 18.26B | 17.70B | 17.23B | 16.89B | 16.37B | 16.23B | 16.15B | 15.86B | ||||||||||||||||||||||||
| Rest of World Growth | 11.58% | 9.06% | 6.74% | 6.51% | 3.58% | 3.90% | 5.40% | 5.52% | ||||||||||||||||||||||||
| United States | 18.10B | 17.78B | 17.52B | 17.31B | 17.17B | 16.97B | 16.85B | 16.72B | ||||||||||||||||||||||||
| United States Growth | 5.43% | 4.80% | 4.01% | 3.54% | 3.67% | 1.62% | 1.27% | 1.14% |
| Period Ending | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative | 11.78B | 11.45B | 11.21B | 11.00B | 10.85B | 10.89B | 10.85B | 10.78B | |||||||||
| Selling, General, and Administrative Growth | 8.60% | 5.09% | 3.31% | 2.06% | 1.05% | 2.89% | 3.04% | 3.04% | |||||||||
| Research and Development | 2.87B | 2.89B | 2.84B | 2.78B | 2.73B | 2.72B | 2.74B | 2.74B | |||||||||
| Research and Development Growth | 5.16% | 5.99% | 3.50% | 1.38% | -0.15% | 0.81% | 1.82% | 2.69% | |||||||||
| Amortization | 1.77B | 1.93B | 1.90B | 1.85B | 1.81B | 1.66B | 1.67B | 1.68B | |||||||||
| Amortization Growth | -1.94% | 15.94% | 14.23% | 10.44% | 6.80% | -2.00% | -2.52% | -1.58% | |||||||||
| Other Expenses | 387.00M | 142.00M | 102.00M | 46.00M | -23.00M | 439.00M | 461.00M | 464.00M | |||||||||
| Other Expenses Growth | - | -67.65% | -77.87% | -90.09% | - | 920.93% | - | - | |||||||||
| Restructuring | 250.00M | 279.00M | 245.00M | 265.00M | 267.00M | 232.00M | 209.00M | 219.00M | |||||||||
| Restructuring Growth | -6.37% | 20.26% | 17.22% | 21.00% | 18.14% | -43.14% | -50.94% | -47.36% | |||||||||
| Litigation | 112.00M | 303.00M | 263.00M | 263.00M | 317.00M | 147.00M | 125.00M | 190.00M | |||||||||
| Litigation Growth | -64.67% | 106.12% | 110.40% | 38.42% | 112.75% | 96.00% | 66.67% | 1,800.00% |